Severe Uncontrolled Atopic Dermatitis
1 clinical trials · Condition
◉ Watch Severe Uncontrolled Atopic Dermatitis
| Record | Firm | Date |
|---|---|---|
| Pre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842) (NCT05466578) | Pfizer |
Track Severe Uncontrolled Atopic Dermatitis automatically
Every clearance here is in the API, with alerts when new ones post.